volume 18 issue 1 pages 5-22

Neurochemical mechanisms and pharmacology of ghrelins

Petr D Shabanov 1
Andrei A Lebedev 2
Eugenii R. Bychkov 2
Nikanor V Lavrov 3
Vitalii I. Morozov 2
Publication typeJournal Article
Publication date2020-05-13
scimago Q4
SJR0.130
CiteScore0.5
Impact factor
ISSN16834100, 25421875
General Medicine
Abstract

The purpose of the review was to analyze the neurochemical and neurophysiological mechanisms of the ghrelin system and the role of ghrelin in body functions and behavior. The focus is on the participation of ghrelin in the mechanisms of reinforcement and the formation of addictive behavior. At the beginning of the review a history of the first works on the field of ghrelin and its receptor was described. Then, genetic control, molecular precursor of ghrelin, molecular forms of ghrelin and ghrelin receptor were represented. In particular, the distribution of the ghrelin receptor, ghrelin-producing cells in the brain and its participation in various physiological functions of the body were shown. The hypothalamic functions of ghrelin were discussed: energy balance, regulation of glucose metabolism, stimulation of eating behavior, regulation of hypophys-pituitary axis (HPA) system. The connection of ghrelin with the brain CRH system was demonstrated. In particular, activation of HPA was described as a possible mechanism through which ghrelin regulates a number of physiological processes. Extrahypothalamic action of ghrelin was shown on the basis of the mechanisms of reinforcement and addiction. On the basis of their own data and literary, it was concluded that action of alcohol and psychoactive drugs are reduced after the ghrelin receptors blockade. In particular, it has been demonstrated that alcoholization of mothers affects the activity of the ghrelin system during the prenatal and early postnatal periods of development in the offspring of rats. It was shown the participation of ghrelin in memory and learning. The further perspective of the study and practical application of ghrelin-based pharmacological agents was analyzed.

Found 
Found 

Top-30

Journals

1
2
3
Reviews on Clinical Pharmacology and Drug Therapy
3 publications, 75%
Neuroscience and Behavioral Physiology
1 publication, 25%
1
2
3

Publishers

1
2
3
Eco-Vector LLC
3 publications, 75%
Springer Nature
1 publication, 25%
1
2
3
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
4
Share
Cite this
GOST |
Cite this
GOST Copy
Shabanov P. D. et al. Neurochemical mechanisms and pharmacology of ghrelins // Reviews on Clinical Pharmacology and Drug Therapy. 2020. Vol. 18. No. 1. pp. 5-22.
GOST all authors (up to 50) Copy
Shabanov P. D., Lebedev A. A., Bychkov E. R., Lavrov N. V., Morozov V. I. Neurochemical mechanisms and pharmacology of ghrelins // Reviews on Clinical Pharmacology and Drug Therapy. 2020. Vol. 18. No. 1. pp. 5-22.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.17816/RCF1815-22
UR - https://doi.org/10.17816/RCF1815-22
TI - Neurochemical mechanisms and pharmacology of ghrelins
T2 - Reviews on Clinical Pharmacology and Drug Therapy
AU - Shabanov, Petr D
AU - Lebedev, Andrei A
AU - Bychkov, Eugenii R.
AU - Lavrov, Nikanor V
AU - Morozov, Vitalii I.
PY - 2020
DA - 2020/05/13
PB - Eco-Vector LLC
SP - 5-22
IS - 1
VL - 18
SN - 1683-4100
SN - 2542-1875
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2020_Shabanov,
author = {Petr D Shabanov and Andrei A Lebedev and Eugenii R. Bychkov and Nikanor V Lavrov and Vitalii I. Morozov},
title = {Neurochemical mechanisms and pharmacology of ghrelins},
journal = {Reviews on Clinical Pharmacology and Drug Therapy},
year = {2020},
volume = {18},
publisher = {Eco-Vector LLC},
month = {may},
url = {https://doi.org/10.17816/RCF1815-22},
number = {1},
pages = {5--22},
doi = {10.17816/RCF1815-22}
}
MLA
Cite this
MLA Copy
Shabanov, Petr D., et al. “Neurochemical mechanisms and pharmacology of ghrelins.” Reviews on Clinical Pharmacology and Drug Therapy, vol. 18, no. 1, May. 2020, pp. 5-22. https://doi.org/10.17816/RCF1815-22.